8-K: Runway Growth Q3 2025: Mixed Results, SWK Merger Announced

Runway Growth Finance Corp. reported third quarter 2025 financial results, including $36.7 million in total investment income, and announced a strategic merger agreement with SWK Holdings Corporation.

Summary

• Total investment income for the third quarter ended September 30, 2025, was $36.7 million.
• Net investment income for the quarter was $15.7 million, or $0.43 per share.
• Net asset value stood at $489.5 million, or $13.55 per share, as of September 30, 2025.
• The dollar-weighted annualized yield on debt investments for the quarter was 16.8%.
• Funded 11 investments in new and existing portfolio companies, representing $128.3 million in gross funded investments during the quarter.
• Repurchased 397,983 shares for an aggregate purchase price of $4.4 million during the quarter.
• Declared a fourth quarter 2025 dividend of $0.33 per share, payable on December 3, 2025, to stockholders of record as of November 17, 2025.
• Entered into an Agreement and Plan of Merger with SWK Holdings Corporation on October 9, 2025, to expand healthcare and life sciences exposure.
• The SWK merger involves SWK stockholders electing to receive either newly issued shares of Runway Growth common stock or cash, plus an additional cash amount from Runway Growth Capital LLC (RGC).
• A key stockholder, Double Black Diamond Offshore Ltd., owning approximately 69.9% of SWK Common Stock, has agreed to vote in favor of the merger.

Sentiment

Score: 6

Explanation: Mixed financial results with a significant decline in net assets from operations and unrealized losses, but offset by a strong strategic acquisition of SWK Holdings, a high investment yield, and share repurchases. The acquisition provides a clear growth path and industry diversification.

Positives

• Achieved a strong dollar-weighted annualized yield on debt investments of 16.8% for the quarter.
• Demonstrated significant investment activity with $128.3 million in gross funded investments across 11 companies during the quarter.
• Announced a strategic acquisition of SWK Holdings Corporation, expected to expand healthcare and life sciences exposure and leverage the BC Partners ecosystem for inorganic growth.
• Executed a share repurchase program, buying back 397,983 shares for $4.4 million during the quarter.
• Net investment income per share increased to $0.43 in Q3 2025 from $0.41 in Q3 2024, despite a slight decrease in total net investment income, reflecting effective capital management.
• Improved core leverage ratio to approximately 92% as of September 30, 2025, down from 105% for the quarter ended June 30, 2025.

Negatives

• Net investment income decreased slightly to $15.7 million in Q3 2025 from $15.9 million in Q3 2024.
• Net increase in net assets resulting from operations significantly decreased to $8.0 million ($0.22 per share) in Q3 2025, compared to $25.0 million ($0.65 per share) in Q3 2024.
• Net asset value per share decreased to $13.55 as of September 30, 2025, from $13.66 as of June 30, 2025.
• Reported a net change in unrealized loss on investments of $6.4 million in Q3 2025, contrasting with a net change in unrealized gain of $9.2 million in Q3 2024.
• Incurred a net realized loss on investments of $1.3 million in Q3 2025, compared to no net realized gains or losses in Q3 2024.

Risks

• The consummation of the SWK merger is subject to various customary closing conditions, including the effectiveness of a Registration Statement, approval by SWK's stockholders, and the absence of a material adverse effect.
• SWK will not be obligated to consummate the merger if a third-party valuation firm values SWK's portfolio assets more than $5.0 million less than SWK's good faith determination of carrying value.
• Actual results may differ materially from forward-looking statements due to a number of factors, including those described in the company's periodic filings with the SEC.

Future Outlook

The company is confident in its position as a destination of choice for growth investment, anticipating benefits from its integration within the BC Partners ecosystem for broader origination channels and inorganic growth initiatives. The proposed acquisition of SWK Holdings is expected to expand healthcare and life sciences exposure, highlighting a key growth lever.

Management Comments

• "Runway Growth continues to make meaningful progress in executing our strategy to scale and optimize our portfolio."
• "Our third quarter investment activity is only beginning to show the benefits of our integration within the BC Partners ecosystem, which enables us to source from a broader set of origination channels."
• "We believe this integration also positions us to pursue inorganic growth initiatives that advance our portfolio, as demonstrated by our proposed acquisition of SWK Holdings following quarter-end."
• "We believe this is a uniquely structured transaction that will expand our healthcare and life sciences exposure, and highlights one of our key growth levers."
• "Looking ahead, we are confident in our position as a destination of choice for growth investment."

Industry Context

The announcement reflects a trend in the Business Development Company (BDC) sector towards strategic M&A to enhance specialized portfolio exposure, particularly in high-growth areas like healthcare and life sciences. Leveraging affiliate ecosystems, such as BC Partners, for deal sourcing and inorganic growth is a common strategy for BDCs seeking to optimize and scale their portfolios in a competitive alternative financing landscape.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess performance against global benchmarks.
• The dollar-weighted annualized yield on debt investments of 16.8% is generally considered strong within the BDC industry, which often targets high-yield debt investments in growth-stage companies.

Corporate Governance

Related Party Transactions

• Runway Growth is externally managed by Runway Growth Capital LLC, an affiliate of BC Partners Advisors L.P.
• Runway Growth Capital LLC (RGC) will provide an additional cash amount to SWK stockholders as part of the merger consideration.

Stakeholder Impact

• **Shareholders**: Impacted by the Q4 2025 dividend declaration ($0.33 per share), share repurchases ($4.4 million), and the potential dilution or value creation from the SWK merger (depending on stock vs. cash election and merger success).
• **Portfolio Companies**: Continued investment activity with $128.3 million funded in new and existing companies.
• **SWK Holdings Stockholders**: Will receive consideration (stock or cash) for their shares as part of the merger.
• **Employees**: Not directly mentioned, but the merger implies integration and potential changes for employees of both entities.

Next Steps

• Hold a conference call on November 6, 2025, to discuss Q3 2025 financial results.
• Prepare and file a registration statement on Form N-14 for the SWK merger.
• Call, give notice of, convene, and hold a special meeting of SWK stockholders to approve the merger.
• Obtain certain regulatory and third-party consents for the merger.
• Consummate the multi-step merger with SWK Holdings Corporation, subject to various closing conditions.

Key Dates

Recommendation

While Runway Growth reported a significant decline in net assets from operations and unrealized losses in Q3 2025, the strategic acquisition of SWK Holdings Corporation is a notable positive, expanding exposure to the healthcare and life sciences sectors and leveraging the BC Partners ecosystem for growth. The company also maintains a strong dollar-weighted annualized yield on debt investments (16.8%) and has been active in share repurchases. The mixed financial performance, coupled with a strategically sound but complex acquisition, suggests a 'hold' position as investors await further clarity on the merger's integration and its impact on future financial performance.

Keywords

Runway Growth Finance, RWAY, BDC, Business Development Company, Venture Debt, Growth Stage Companies, SEC Filing, Q3 2025 Earnings, Financial Results, SWK Holdings, Merger Agreement, Acquisition, Healthcare Investment, Life Sciences, Investment Portfolio, Net Asset Value, Dividends, Share Repurchase, BC Partners